TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for BiomX Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-04 7:59 pm Unchanged | 2022-03-25 | 13G | BiomX Inc. PHGE | TAKEDA PHARMACEUTICAL CO LTD | 147,829 4.960% | 0 (Unchanged) | Filing |
| 2021-10-18 06:03 am Sale | 2021-10-14 | 13G | BiomX Inc. PHGE | TAKEDA PHARMACEUTICAL CO LTD | 147,829 5.200% | -99,265 (-40.17%) | Filing |